According to Data Bridge Market Research new Market report, Global PCR Devices Market By Product Type (Instrument, Reagents, Consumables, Others), By Technology (Digital PCR, Real-Time PCR ), By Application (Oncology, Blood Testing, Pathogen Detection, Research, Forensic, Others ), By End-Users (Hospital, Diagnostic Center, Pharmaceutical, Biotechnology Companies, Clinical Research Organizations, Academia, Laboratories ), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast is projected to reach USD 5.56 billion by 2025, at a CAGR of 9.8% during the forecast period of 2018 to 2025 – Industry Trends and Forecast to 2025
Access Full Report : https://databridgemarketresearch.com/reports/global-pcr-devices-market/
Polymerase chain reaction (PCR) is a technique of producing a number of replicas of a particular DNA sequence, which involves recurrent reactions with a polymerase. PCR is extremely useful in studying the operation of targeted segment and forensic examinations. This method shows high efficiency in detection and the monitoring of genetic diseases. Today the use of PCR in diagnostic laboratories of pharmaceutical and biotechnology companies is rapidly increasing.
Chinese in-vitro Diagnostics Company (Righton) and Akonni Biosystems Inc In March 2018 have signed a commercial agreement. This agreement enables Righton to sell Akonni's TruDiagnosis and TruTip nucleic acid purification kits in China.
Thermo Fisher Scientific and Illumina, Inc in January 2018 has signed a commercial agreement. According to this agreement, Thermo Fisher will provide Ion AmpliSeq technology to Illumina for research purpose.
Genome Diagnostics (GenDx) in December 2017 had signed a global reseller agreement with Thermo Fisher Scientific, assigning GenDx as a non-exclusive reseller of Thermo Fisher’s QuantStudio real-time PCR instrument. GenDx will market the QuantStudio real-time PCR in the Netherlands and other European countries.
The global market for PCR devices by the following sub-categories is presented
Rising incidences of infectious diseases and genetic disorders:
There are various diseases which are diagnosed using PCR, These are Hantavirus infection, rebella virus, measles virus, laptospira, tuberculosis, lyme disease.
According to Center for Disease Control and Prevention in January 2017, 728 cases of hanta virus infection was reported in United States. This infection was laboratory confirmed that who have either Hantavirus Pulmonary Syndrome (HPS) or non-pulmonary Hantavirus infection. Of this 36.0% of people died because of HPS. Men (63.0%) are more exposed to this as compare to women (37.0%).
According to National Cancer Institute, Human Papillomavirus is the most common sexually transmitted infection in the United States. There are around 24 million active cases and 5.5 million new cases each year.
According to world health organization, when the rubella virus infects a woman in her early pregnancy stage, she has a 90% chance of passing the virus on to her fetus. This can cause miscarriage, stillbirth or severe birth defects known as congenital rubella syndrome. Before the introduction of the vaccine, up to 4 babies in every 1000 live births were born with congenital rubella syndrome.
As the prevalence of the above mentioned diseases are increasing year after year, hence demand for PCR devices is expected to increase and will have a stable growth in future.
Technological advancements in the field of PCR:
In October 2017, Diatech Pharmacogenetics srl launched easyPGX, which is a a ready to use in-vitro diagnostic real-time PCR product line. And launched Helix which is a polymerase chain reaction kit for the extraction of circulating free DNA from plasma.
In November 2014, chai biotechnologies Inc. introduced open qPCR which is a real-time PCR Thermocycler. The new instrument can be effectively used use for pathogen detection, genetic genotyping, and relative DNA quantification.
In April 2014, Bio-Rad Laboratories launched Precision Blue Real-Time PCR Dye. The new Precision Blue dye is well-matched with Bio-Rad’s universal qPCR supermixes, and is suitable to use with all Bio-Rad’s CFx real time PCR systems.
Hence with new technological advancements in PCR, and with new product launches, the demand for PCR devices will increase, hence giving this market a inclining growth in future.
Some of the major market players in this market are Thermo Fisher Scientific Inc, Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche Ltd, QIAGEN, Takara Bio Inc, Agilent Technologies, bioMérieux SA, Fluidigm Corporation, Danaher, Abbott, Biocartis, BD, Eppendorf AG, Sigma-Aldrich Co, Merck KGaA, Beckman Coulter, Inc, PerkinElmer Inc, METTLER TOLEDO, Promega Corporation, Sartorius AG, New England Biolabs.
Browse Related Reports:
Global Bioburden Testing Market, By Test Type (Aerobic, Anaerobic, Fungi, Spore), By Product Type (Instruments (PCR, Automated Microbial Identification Systems, Microscopes, Others), Consumables (Kits & Strips, Reagents, Others), By Technology (Microbial Filter Method, Advanced Colorimetric Method, Plate Count Method, Rapid Testing), By Application (Raw Material Testing, In-Process Testing, Medical Device Testing, Pharmaceutical & Cosmetic Testing, Food and Beverage Testing), By End-User (Pharmaceutical, Biotechnology, Industrial, Food & Beverages), By Geography (North America, Europe, Asia-Pacific, South America and Middle East Asia) – Trends and Forecast to 2024.
Europe Biopreservation Market By Product Type, By End User, By Country (Germany, France, United kingdom, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe) – Industry Trends and Forecast to 2024.
Global Metabolic Testing Market, By Product (CPET Systems, Metabolic Carts, ECG & EKG Systems, Body Composition Analyzers, Software), By Application (Lifestyle Diseases, Critical Care, Human Performance Testing , Dysmetabolic Syndrome X, Metabolic Disorders), By Technology (VO2 Max Analysis, RMR Analysis, Body Composition Analysis), By End User (Hospitals, Laboratories, Sports Training Centers, GYMS), By Geography – Industry Trends and Forecast to 2025.
North America In-Situ Hybridization Devices Market By Product Type, By End User, By Country (U.S.A, Canada, Mexico) – Industry Trends and Forecast to 2024.
North America PCR Devices Market – Industry Trends and Forecast to 2026
North America q-PCR and d-PCR Devices Market – Industry Trends and Forecast to 2027
Europe PCR Devices Market – Industry Trends and Forecast to 2026
Asia-Pacific PCR Devices Market – Industry Trends and Forecast to 2026
Asia-Pacific q-PCR and d-PCR Devices Market – Industry Trends and Forecast to 2027
Global PCR devices Market – Industry Trends - Forecast to 2026
Europe Q-PCR and D-PCR Devices Market - Industry Trends and Forecast to 2026
Global Q-PCR and D-PCR Devices Market - Industry Trends and Forecast to 2026
Global PCR Devices Market Rising at 9.00% CAGR due to Low Reagent Consumption